{"DataElement":{"publicId":"2529197","version":"1","preferredName":"Loss Gene Expression Immunohistochemistry Staining Method Finding Present Benign Tissue BenignPresent","preferredDefinition":"A gradual decline in amount or activity.:Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.:Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.:Objective evidence of disease perceptible to the examining physician (sign) and subjective evidence of disease perceived by the patient (symptom)._Being or existing in a specified place or at the specified time.:Mild in nature, not dangerous to health.  It is used to describe neoplastic processes which are not locally invasive and do not metastasize.:An aggregate of cells with similar or identical specialized characteristics, contributing to the performance of a specific function.  Tissues are parts of organs._BenignPresent pertains to whether there is  benign tissue present in specimen","longName":"2528902v1.0:2529047v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2528902","version":"1","preferredName":"Loss Gene Expression Immunohistochemistry Staining Method Finding Present Benign Tissue","preferredDefinition":"A gradual decline in amount or activity.:Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.:Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.:Objective evidence of disease perceptible to the examining physician (sign) and subjective evidence of disease perceived by the patient (symptom)._Being or existing in a specified place or at the specified time.:Mild in nature, not dangerous to health.  It is used to describe neoplastic processes which are not locally invasive and do not metastasize.:An aggregate of cells with similar or identical specialized characteristics, contributing to the performance of a specific function.  Tissues are parts of organs.","longName":"2528742v1.0:2528656v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2528742","version":"1","preferredName":"Loss Gene Expression Immunohistochemistry Staining Method Finding","preferredDefinition":"A gradual decline in amount or activity.:Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.:Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.:Objective evidence of disease perceptible to the examining physician (sign) and subjective evidence of disease perceived by the patient (symptom).","longName":"C25559:C16608:C23020:C3367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Loss","conceptCode":"C25559","definition":"A gradual decline in amount or activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Gene Expression","conceptCode":"C16608","definition":"Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"20415841-395F-0263-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-20","endDate":null,"createdBy":"UMLLOADER_CGOM","dateCreated":"2006-10-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2528656","version":"1","preferredName":"Present Benign Tissue","preferredDefinition":"Being or existing in a specified place or at the specified time.:Mild in nature, not dangerous to health.  It is used to describe neoplastic processes which are not locally invasive and do not metastasize.:An aggregate of cells with similar or identical specialized characteristics, contributing to the performance of a specific function.  Tissues are parts of organs.","longName":"C25626:C14172:C12801","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Benign","conceptCode":"C14172","definition":"For neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For other conditions, a process that is mild in nature and not dangerous to health.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tissue","conceptCode":"C12801","definition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2041482A-8C74-6D6B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-20","endDate":null,"createdBy":"UMLLOADER_CGOM","dateCreated":"2006-10-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"20416C18-E829-1311-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-20","endDate":null,"createdBy":"UMLLOADER_CGOM","dateCreated":"2006-10-20","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2529047","version":"1","preferredName":"Benign Present Indicator","preferredDefinition":"BenignPresent pertains to whether there is  benign tissue present in specimen_An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"2529047v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"benign_tissue_present","valueDescription":"Present Benign Tissue","ValueMeaning":{"publicId":"2581869","version":"1","preferredName":"Present Benign Tissue","longName":"2581869","preferredDefinition":"Being or existing in a specified place or at the specified time.:Mild in nature, not dangerous to health.  It is used to describe neoplastic processes which are not locally invasive and do not metastasize.:An aggregate of cells with similar or identical specialized characteristics, contributing to the performance of a specific function.  Tissues are parts of organs.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0CDA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-13","endDate":null,"createdBy":"CURTIST","dateCreated":"2006-11-13","modifiedBy":"CURTIST","dateModified":"2006-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2229366E-BC16-5AA7-E044-0003BA3F9857","beginDate":"2006-11-13","endDate":null,"createdBy":"CURTIST","dateCreated":"2006-11-13","modifiedBy":"CURTIST","dateModified":"2006-11-13","deletedIndicator":"No"},{"value":"no_benign_tissue_present","valueDescription":"Negation Present Benign Tissue","ValueMeaning":{"publicId":"2581872","version":"1","preferredName":"Negation Present Benign Tissue","longName":"2581872","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.:Being or existing in a specified place or at the specified time.:Mild in nature, not dangerous to health.  It is used to describe neoplastic processes which are not locally invasive and do not metastasize.:An aggregate of cells with similar or identical specialized characteristics, contributing to the performance of a specific function.  Tissues are parts of organs.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0CDD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-13","endDate":null,"createdBy":"CURTIST","dateCreated":"2006-11-13","modifiedBy":"CURTIST","dateModified":"2006-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2229366E-BC22-5AA7-E044-0003BA3F9857","beginDate":"2006-11-13","endDate":null,"createdBy":"CURTIST","dateCreated":"2006-11-13","modifiedBy":"CURTIST","dateModified":"2006-11-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2320047","version":"1","preferredName":"Indicator","preferredDefinition":"An event, entity or condition that typically characterizes a prescribed environment or situation. Indicators determine or aid in determining whether or not certain stated circumstances exist or criteria are satisfied. (On-line Medical Dictionary)","longName":"C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FC6EF0D8-521A-6865-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"20417B5E-7B18-1F39-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-20","endDate":null,"createdBy":"UMLLOADER_CGOM","dateCreated":"2006-10-20","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":"Representation term 'Indicator' added per request of loading team to suport SIW requirements on 7/31/2008","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2528519","version":"2","longName":"caIntegrator","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812323","version":"1","longName":"gov.nih.nci.caintegrator.domain.finding.protein.ihc","context":"NCIP"}]},{"publicId":"2707890","version":"2.1","longName":"caIntegrator 2.1","context":"NCIP","ClassificationSchemeItems":[{"publicId":"10000564","version":"1","longName":"gov.nih.nci.caintegrator.domain.finding.protein.ihc","context":"NCIP"}]}],"AlternateNames":[{"name":"LossOfExpressionIHCFinding:benignPresentValue","type":"UML Class:UML Attr","context":"NCIP"},{"name":"gov.nih.nci.caintegrator.domain.finding.protein.ihc.LossOfExpressionIHCFinding.benignPresentValue","type":"UML Qualified Attr","context":"NCIP"}],"ReferenceDocuments":[{"name":"Data Element Loss Gene Expression Immunohistochemistry Staining Method Finding Present Benign Tissue BenignPresent does not have Preferred Question Text","type":"Preferred Question Text","description":"Data Element Loss Gene Expression Immunohistochemistry Staining Method Finding Present Benign Tissue BenignPresent does not have Preferred Question Text","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"20408DF8-C797-306C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-20","endDate":null,"createdBy":"UMLLOADER_CGOM","dateCreated":"2006-10-20","modifiedBy":"CURTIST","dateModified":"2008-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}